# Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly

> **NCT00413088** · PHASE1 · COMPLETED · sponsor: **Rovi Pharmaceuticals Laboratories** · enrollment: 60 (estimated)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** bemiparin

## Key facts

- **NCT ID:** NCT00413088
- **Lead sponsor:** Rovi Pharmaceuticals Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413088, "Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00413088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*